Ned Tijdschr Geneeskd. 1990 Apr; 134(14): 693-7.

[Rheumajecta and Vasolastine treatment of primary fibromyalgia; results of a randomized placebo-controlled double-blind study]

Jacobs JW, Rasker JJ, van Riel PL, Gribnau FW, van de Putte LB.

Medisch Spectrum Twente, afd. Reumatologie, Enschede.

Rheumajecta and Vasolastine (R and V) are preparations belonging to complementary medicine. They are applied in rheumatic conditions such as primary fibromyalgia. In this double-blind, modified cross-over trial, the effect of R and V injections was compared with that of placebo over two periods of three months in 30 patients with primary fibromyalgia. No significant differences in effectiveness between R and V and placebo were seen. There were no serious side-effects. R and V are not indicated for primary fibromyalgia unless no more effect than that of placebo is intended.